Publications by authors named "Gerardo Medea"

Claim this Profile
M
Mediterranean diet for the management of pre-existing metabolic diseases: Evidence from a systematic review and meta-analysis featured in the Italian national guidelines "La Dieta Mediterranea".
Giovanna Muscogiuri, Maria Ida Maiorino, Barbara Paolini, Fiorella Aversano, Carola Buscemi, Gerardo Medea

Nutrition· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To assess the patterns of use of ASA-statin free combinations in primary care: a population-based study in Italy.
Francesco Lapi, Ettore Marconi, Gerardo Medea, Alessandro Rossi, Iacopo Cricelli

Endocrine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SICOB Italian clinical practice guidelines for the surgical treatment of obesity and associated diseases using GRADE methodology on bariatric and metabolic surgery.
Maurizio De Luca, Monica Zese, Giulia Bandini, Marco Antonio Zappa, Ugo Bardi, Gerardo Medea

Updates Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects.
Rocco Barazzoni, Silvio Buscemi, Luca Busetto, Paolo Sbraccia, Simona Bo, Gerardo Medea

Eat Weight Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects.
Rocco Barazzoni, Silvio Buscemi, Luca Busetto, Paolo Sbraccia, Simona Bo, Gerardo Medea

Eat Weight Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SICOB Italian Clinical Practice GRADE-based guidelines for the endobariatric treatment of overweight, obesity, and obesity-associated diseases.
Maurizio De Luca, Amanda Belluzzi, Monica Zese, Andrea Anderloni, Rosario Bellini, Gerardo Medea

Updates Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care.
Francesco Lapi, Ettore Marconi, Gerardo Medea, Iacopo Cricelli, Damiano Parretti

Endocrine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and yearly trend of obesity and overweight in primary care in Italy.
Francesco Lapi, Ettore Marconi, Gerardo Medea, Ignazio Grattagliano, Alessandro Rossi

Intern Emerg Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interplay between excess weight and hyper-glycemia on NCDs in Italy: results from a cross-sectional study.
Vincenzo Atella, Federico Belotti, Matilde Giaccherini, Gerardo Medea, Andrea Piano Mortari

Acta Diabetol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upcoming Italian clinical practice guidelines on endoscopic bariatric treatment of overweight and obesity: design and methodological aspects.
Maurizio De Luca, Antonio Silverii, Monica Zese, Giovanni Galasso, Rosario Bellini, Gerardo Medea

Updates Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects.
Matteo Monami, Alessia Scatena, Cesare Miranda, Luca Monge, Alessandro De Cassai, Gerardo Medea

Acta Diabetol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Valentina Perrone, Gerardo Medea, Stefano Urbinati, Diego Sangiorgi, Luca Degli Esposti

Glob Reg Health Technol Assess· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Kidney Disease Eligible for SGLT2 Inhibitors Through the Integration of Italian Administrative and Primary Care Data.
Carlo Piccinni, Letizia Dondi, Silvia Calabria, Giulia Ronconi, Antonella Pedrini, Gerardo Medea

G Ital Nefrol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome.
Marco Meloni, Laura Giurato, Luca Monge, Cesare Miranda, Alessia Scatena, Gerardo Medea

Acta Diabetol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime costs of overweight and obesity in Italy.
Vincenzo Atella, Federico Belotti, Matilde Giaccherini, Gerardo Medea, Antonio Nicolucci

Econ Hum Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To retrieve values of albuminuria to define the size of CKD patients eligible to SGLT-2Is: An explorative analysis using a primary care database.
Francesco Lapi, Ettore Marconi, Gaetano Piccinocchi, Gerardo Medea, Carlo Piccinni

Pharmacoepidemiol Drug Saf· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Italian clinical practice guidelines for the treatment of diabetic foot syndrome: design and methodological aspects.
Matteo Monami, Alessia Scatena, Cesare Miranda, Luca Monge, Alessandro De Cassai, Gerardo Medea

Acta Diabetol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes.
Francesco Lapi, Elisa Bianchini, Ettore Marconi, Gerardo Medea, Carlo Piccinni

Pharmacoepidemiol Drug Saf· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes.
Francesco Lapi, Ettore Marconi, Gerardo Medea, Damiano Parretti, Carlo Piccinni

Endocrine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023 update on Italian guidelines for the treatment of type 2 diabetes.
Edoardo Mannucci, Riccardo Candido, Lina Delle Monache, Marco Gallo, Andrea Giaccari, Gerardo Medea

Acta Diabetol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To predict the risk of chronic kidney disease (CKD) using Generalized Additive2 Models (GA2M).
Francesco Lapi, Lorenzo Nuti, Ettore Marconi, Gerardo Medea, Iacopo Cricelli

J Am Med Inform Assoc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient healthcare costs associated with overweight and obesity in Italy.
Vincenzo Atella, Federico Belotti, Claudio Cricelli, Matilde Giaccherini, Gerardo Medea

BMC Health Serv Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early identification of chronic kidney disease: it is time to enhance patient and population-based informatics tools for general practitioners.
Francesco Lapi, Ettore Marconi, Gaetano Piccinocchi, Iacopo Cricelli, Gerardo Medea

Curr Med Res Opin· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases.
Carlo Piccinni, Letizia Dondi, Silvia Calabria, Giulia Ronconi, Antonella Pedrini, Gerardo Medea

Int J Cardiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updating obesity management strategies: an audit of Italian specialists.
Luca Busetto, Maria Grazia Carbonelli, Antonio Caretto, Annamaria Colao, Claudio Cricelli, Gerardo Medea

Eat Weight Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis